Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-15-076827

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HILL STEPHEN A · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-10-22 Grant or award : show line 1 in the form Stock Option (Right to Buy) +8,250 $4.40 2025-10-22 8,250 8,250 D
2015-10-22 Grant or award : show line 2 in the form Stock Option (Right to Buy) +6,750 $4.40 2025-10-22 6,750 6,750 D
Loading xslF345X03/doc4.xml…